4//SEC Filing
Ways Kirk 4
Accession 0001209191-22-032505
CIK 0001683553other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 4:13 PM ET
Size
5.5 KB
Accession
0001209191-22-032505
Insider Transaction Report
Form 4
Ways Douglas Kirk
DirectorInterim Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-05-25+20,625→ 20,625 totalExercise: $1.32Exp: 2032-05-24→ Common Stock (20,625 underlying)
Footnotes (1)
- [F1]The shares vest on the first anniversary of the Grant Date, provided that the Option will in any case be fully vested on the date of Company's 2023 annual stockholder meeting, subject to the Reporting Person's Continuous Service (as defined in the 2020 Equity Incentive Plan (the "Plan")) through such vesting date and will vest in full upon a Change in Control (as defined in the Plan).
Documents
Issuer
SPRUCE BIOSCIENCES, INC.
CIK 0001683553
Entity typeother
Related Parties
1- filerCIK 0001869391
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 4:13 PM ET
- Size
- 5.5 KB